Webinars Post

Welcome to the new marketing jungle

Too long we’ve spent in the digital wilderness – tweaking aging processes, fiddling at the edges, and hitting our heads against digital and compliance...

Admin - April 23, 2021

Webinars Post

The path to market for digital health solutions

Pharma's approach to digital healthcare products is maturing. The era of experimental pilot apps is being replaced with a more sophisticated and strategic approach....

Admin - April 23, 2021

Webinars Post

BMS, GSK and Astellas join OKRA to discuss the answer to uncertainty

We live in an increasingly digital world. Even more so following Covid-19. As our field forces transition to an online/hybrid model, we start to think...

Admin - April 23, 2021

Webinars Post

Digital companions – the future of holistic patient support

Adherence can no longer be the solitary focus of patient support. If we want treatment it be successful, it is our duty to care...

Admin - April 22, 2021

Webinars Post

5 changes you have to make right now: Accelerating HCP engagement post-crisis

Eight in ten doctors anticipate a permanent increase in virtual or remote interactions with sales representatives. To stay ahead of the competition, we need...

Admin - April 22, 2021

Webinars Post

Patient engagement in Covid-19

Patient engagement and PSP creation have, like many things, been turned upside down in this pandemic. And while it may be easier to reach...

Admin - April 22, 2021

12 3...5 Page 1 of 5

Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age

Editor´s Pick September 28, 2021

Dicerna Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigational GalXC™ RNAi Therapeutic Candidate for the Treatment of Alcohol Use Disorder

Industry News September 28, 2021

Oncoinvent Announces Advancement of Radspherin® to Fourth Dose Level Cohort in Ongoing RAD-18-001 Phase 1 Trial in Ovarian Cancer Patients

Industry News September 28, 2021

MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors

Look Who’s On the Move! September 28, 2021

Seagen Announces Last Patient Enrolled in Phase 2 MOUNTAINEER Trial Evaluating TUKYSA® (Tucatinib) Regimen in HER2-Positive Metastatic Colorectal Cancer

Industry News September 28, 2021

Webinars Post

Recent Articles

Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program

ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS® COVID-19 Antigen Rapid Test Kit

Medidata Veterans Rama Kondru and Sastry Chilukuri Named co-CEOs

ASC Therapeutics Appoints Gene and Cell Therapy Manufacturing Veteran Gary Potter to lead Global Operations

Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age

Mednow Announces Executive Appointments to Accelerate its Institutional Services Business

Cycle Pharmaceuticals launches SAJAZIRTM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE)

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

Dicerna Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigational GalXC™ RNAi Therapeutic Candidate for the Treatment of Alcohol Use Disorder

Oncoinvent Announces Advancement of Radspherin® to Fourth Dose Level Cohort in Ongoing RAD-18-001 Phase 1 Trial in Ovarian Cancer Patients

MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors

Seagen Announces Last Patient Enrolled in Phase 2 MOUNTAINEER Trial Evaluating TUKYSA® (Tucatinib) Regimen in HER2-Positive Metastatic Colorectal Cancer

Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan

Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer